FDA.reportPublic FDA data

treprostinil 80 MCG Inhalation Powder

RxCUI
2697737
RxNorm name
treprostinil 80 MCG Inhalation Powder
Display name
treprostinil 80 MCG Inhalation Powder
Full name
treprostinil 80 MCG Inhalation Powder
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Tyvaso DPITREPROSTINILUnited Therapeutics Corporationddc3d400-bcb3-4b09-aae2-0768b10a5b0f2025-11-20Warnings, Adverse reactionsExact identifier
rxcui: 2697737

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ddc3d400-bcb3-4b09-aae2-0768b10a5b0ftreprostinil 80 MCG Inhalation Powder [PSN] · treprostinil 0.08 MG Inhalation Powder [SCD] · treprostinil 80 MCG Inhalation Powder [SY]314These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120